Reports Q4 revenue $109.7M, consensus $108.9M. “We are pleased with our solid finish to fiscal 2025 and I am excited about the new products we have introduced over the past several quarters that improve medication adherence and the overall patient and provider experience,” said CEO and Co-Founder Chaim Indig.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PHR: